C13H17NO8
Neat
315.28
+5°C
Room Temperature
1335210-23-5; 1-(2, 2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1, 4-dihydropyridine-3-carboxylic acid; J4HZW9J2C5; RefChem:1053798; Dolutegravir intermediate-1; 1-(2, 2-Dimethoxyethyl)-1, 4-dihydro-3-methoxy-4-oxo-2, 5-pyridinedicarboxylic acid 2-methyl ester; MFCD28978322; C13H17NO8; 1-(2, 2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid; 1-(2, 2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxo-pyridine-3-carboxylic acid; 1-[2, 2-Bis(methyloxy)ethyl]-5-(methyloxy)-6-[(methyloxy)carbonyl]-4-oxo-1, 4-dihydro-3-pyridinecarboxylic acid; 1-(2, 2-BIS(METHYLOXY)ETHYL)-5-(METHYLOXY)-6-((METHYLOXY)CARBONYL)-4-OXO-1, 4-DIHYDRO-3-PYRIDINECARBOXYLIC ACID; 2, 5-Pyridinedicarboxylic acid, 1-(2, 2-dimethoxyethyl)-1, 4-dihydro-3-methoxy-4-oxo-, 2-methyl ester; 1-(2, 2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1, 4-dihydropyridine-3-carboxylic acid; 1-[2, 2-Bis(methyloxy)ethyl]-5-(methyloxy)-6-[(methyloxy)carbonyl]-4-oxo-1, 4-dihydro-3-pyridinecarboxylic acid; DHPA; GSK 2598836A; Dolutegravir related; 2, 5-PYRIDINEDICARBOXYLIC ACID, 1-(2, 2-DIMETHOXYETHYL)-1, 4-DIHYDRO-3-METHOXY-4-OXO- and 2-METHYL ESTER; orb1309751; SCHEMBL2415069; XAXGEECGULRZGN-UHFFFAOYSA-N; KDC21023; AKOS027339716; AC-30660
1-(2 and 2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid
InChI=1S/C13H17NO8/c1-19-8(20-2)6-14-5-7(12(16)17)10(15)11(21-3)9(14)13(18)22-4/h5,8H,6H2,1-4H3,(H,16,17)